CBMG inks Kymriah deal: ‘China could take the lead in cell therapies’
CBMG announced a manufacturing collaboration agreement with Novartis at the end of last month to produce CAR-T treatment Kymriah for the Chinese market and the company has further ambitions in the pipeline.